Daniel Freeman
- Role
- Vice President, Early Development Oncology at AstraZeneca
- Location
- Washington, DC, US
- LinkedIn followers
- 500 followers
About Daniel Freeman
As Vice President in Oncology R&D at AstraZeneca, I lead the early Oncology Projects…
Experience
Vice President, Early Development Oncology
Jun 2016 — Present
Oversee a world-class Oncology R&D project team in the development of immunotherapy, ADCs, radio conjugates, cell therapy, t-cell engagers, epigenetics, tumour drivers and resistance, and DNA damage response agents from early discovery to phase 3 development. With accountability for strategy on both asset and portfolio level, the team has been instrumental in the successful transition of six New Molecular Entities from early to late development in 2021-23.
Education
UCLA
PhD, Molecular and Medical Pharmacology
1998 — 2003
UC Santa Barbara
BS, Pharmacology
1989 — 1993
Skills
- Biomarkers
- Drug Development
- Cancer
- Cell Biology
- Molecular Biology
- Drug Discovery
- Pharmacology
- Biomarker Discovery
- Clinical Trials
- Translational Medicine
- Lifesciences
- Immunology
- Oncology
- Clinical Development
- Assay Development
- Target Identification
- Biotechnology
- Clinical Pharmacology
- In Vivo
- Life Sciences
- Signal Transduction
- Clinical Research
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.